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Guided differentiationThe development of smart interfaces that can guide tissue formation is of great importance in the field of
regenerative medicine. Nanoparticles represent an interesting class of materials that can be used to
enhance regenerative treatments by enabling close control over surface properties and directing cellular
responses. Moreover, nanoparticles can be used to provide temporally controlled delivery of (multiple)
biochemical compounds. Here, we exploited the cargo loading and surface functionalization properties
of mesoporous silica nanoparticles (MSNs) to design films that can guide human mesenchymal stem cell
(hMSC) differentiation towards the osteogenic lineage. We developed biocompatible MSN-based films
that support stem cell adhesion and proliferation and demonstrated that these MSN films simultaneously
allowed efficient local delivery of biomolecules without effecting film integrity. Films loaded with the
osteogenesis-stimulating drug dexamethasone (Dex) were able to induce osteogenic differentiation of
hMSCs in vitro. Dex delivery from the films led to increased alkaline phosphatase levels and matrix min-
eralization compared to directly supplementing Dex to the medium. Furthermore, we demonstrated that
Dex release kinetics can be modulated using surface modifications with supported lipid bilayers.
Together, these data demonstrate that MSN films represent an interesting approach to create biomaterial
interfaces with controllable biomolecule release and surface properties to improve the bioactivity of bio-
materials.
Statement of significance
Engineering surfaces that can control cell and tissue responses is one of the major challenges in
biomaterials-based regenerative therapies. Here, we demonstrate the potential of mesoporous silica
nanoparticles (MSNs) as drug-delivering surface coatings. First, we show differentiation of mesenchymal
stem cells towards the bone lineage when in contact with MSN films loaded with dexamethasone.
Furthermore, we demonstrate that modification of MSNs with supported lipid bilayer allows control over
drug release dynamics and cell shape. Given the range of loadable cargos and the tunability of release
kinetics, MSN coatings can be used to mimic the sequential appearance of bioactive factors during tissue
regeneration, which will ultimately lead to biomaterials with improved bioactivity.
 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
Currently, a major focus in the field of regenerative medicine is
the engineering and development of biomaterials that can repair or
regenerate damaged cells, organs and tissues. Such materials are
expected to temporarily provide sufficient (mechanical) support,
while serving as a matrix for new tissue formation by which they
are eventually replaced. To effectively direct tissue regeneration,control over key stem cell fate processes such as adhesion, prolifer-
ation, migration, and differentiation is needed. Within the body,
the extracellular matrix (ECM) provides multiple chemical and bio-
physical cues that can be sensed by cells to direct these processes.
Synthetic approaches that mimic these cues have been an impor-
tant strategy in the development of instructive biomaterials for tis-
sue engineering and other regenerative medicine applications. For
example, tuning material properties, such as surface chemistry and
surface topography, can guide stem cells to align or even differen-
tiate [1–4]. Chemical approaches include incorporation in, and
release of biomolecules (e.g., growth factors) from biomaterial
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genetic protein 2 (BMP-2) to stimulate bone growth [5–7], which
has obtained market approval. However, biomolecule release from
these scaffolds needs to be tightly controlled to avoid initial burst
release, potentially causing serious side effects as a result of local
supraphysiological concentrations. In addition, uncontrolled bio-
molecule release minimizes the efficacy as prolonged chemical sig-
nalling is not possible [6–8]. Next to other approaches using
polymers, and microparticles [9–11], nanoparticle-based carriers
could increase control over the pharmacokinetics of such agents
owing to their ability to carry high concentrations of (insoluble)
biomolecules, while protecting them from degradation. In addition,
nanoparticles can be surface-modified to allow for sustained drug
delivery to improve the biological performance of biomaterials
by providing temporally controlled release over (multiple) bio-
chemical cues.
Next to their drug delivery capabilities, nanoparticles are inter-
esting materials for designing biomaterial interfaces by offering
ways to closely control surface topographical and chemical proper-
ties to direct adhesion, differentiation and integration of (stem)
cells into the surrounding environment. In this context, meso-
porous silica nanoparticles (MSNs) show interesting properties
for regenerative medicine as they are biocompatible and have
shown promise in several biomedical fields such as in cancer ther-
apy and tumour imaging [12,13]. In addition, the inherent material
properties of MSNs allow for the development of mechanically
stronger materials with higher bioactivity. For example, the incor-
poration of silica nanoparticles into hydrogels has resulted in
increased compressive strength and fracture toughness by an order
of magnitude compared to non-fortified hydrogels [14–16]. Several
studies reported that the incorporation of MSNs in biomaterials
can improve their biological performance, such as enhanced initial
cell adhesion, cell viability, cell spreading, and metabolic activity of
stem cells [17–19]. Moreover, MSNs are easy to functionalize and
their surface chemistry can be used to modulate cell-material
interactions. Latest advances in the synthesis of MSNs allow cap-
ping or closing the pore entry using polymers or lipids, thereby
enabling better control over cargo release [20–22]. Promising
results on the use of surface modifications to control drug release
have been obtained by using supported lipid bilayers (SLB) to pre-
vent premature cargo release from MSNs [23]. Furthermore, SLBs
allow control over the cell-material interface by the ability to
change the chemistry (i.e., lipid content), fluidity (i.e., lipid phase)
and incorporation of additional ligands (e.g., adhesion peptides)
[24].
Here, we hypothesized that the cargo loading and favourable
surface properties of MSNs can be leveraged to design films that
can guide human mesenchymal stem cell (hMSC) behaviour. The
aim was to form biocompatible, stable MSN-based films that sup-
port stem cell adhesion and proliferation. The MSNs porous struc-
ture was used for delivering dexamethasone (Dex) as a showcase,
which is a known stimulator of osteogenic differentiation. The abil-
ity of the films to induce the osteogenic differentiation of hMSCs
and support their ECM formation in vitro was evaluated. Further-
more, we investigated the use of lipid surface modifications to
modulate cell shape and to control release kinetics of incorporated
cargo.2. Material and methods
2.1. Materials
Tetraethyl orthosilicate (TEOS), 3-mercaptopropyl triethylsilane
(MPTES), triethanolamine (TEA), 3-Aminopropyl triethoxysilane
(APTES), cetyltrimethylammonium chloride (CTAC), ammoniumfluoride, hydrochloric acid (37%), ammonium nitrate,
N,N-Dimethylformamide (DMF), ATTO 633–malemeide, 5/6-
carboxyfluorescein succinimidyl ester (NHS-FITC), phosphate-
buffered saline (PBS), foetal bovine serum, ascorbic acid,
bis[N,N-bis(carboxymethyl)aminomethyl]fluorescein (calcein),
dexamethasone (Dex), b-glyerolphosphate (BGP) and hexamethyl-
disilazane (HMDS) were purchased from Sigma Aldrich GmbH
(Germany). Absolute ethanol, paraformaldehyde (PFA), Triton
X-100, bovine serum albumin (BSA), Tween-20 and Alizarin Red
S (sodium alizarin sulphonate) were purchased from VWR (US).
Calcein AM blue, minimum essential medium alpha (aMEM),
L-glutamine and trypsin were purchased from Fisher Scientific
(The Netherlands). Penicillin and streptomycin were purchased
from Gibco Life Technologies (US). 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) were purchased from Avanti Polar Lipids
(US).
2.2. MSN and MSN-DOPC synthesis
Synthesis of MSNs with thiol core functionalization and amine
surface functionalization was performed based on a sol-gel process
reported elsewhere [25]. Synthesis of MSN-DOPC was performed
as reported previously [26], using 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) lipids. Further details on MSN synthesis
and characterization can be found in the supporting information.
2.2.1. Preparation of MSN and MSN-DOPC films
MSN films were prepared using spin-coating on glass cover slips
(diameter 22 mm). Further details on film preparation and charac-
terization can be found in the supporting information.
2.3. hMSC cell culture
hMSCs, obtained with full written consent from the donor, were
expanded in aMEM with addition of 10% FBS, 2 mM L-glutamine,
0.2 mM ascorbic acid, 100 U/ml penicillin and 100 mg/ml strepto-
mycin at 37 C, 5% CO2 in a humidified atmosphere. Cells between
passage 4 and 6 were used for experiments. Seeding density varied
depending on experimental aim (details on seeding densities can
be found in individual experimental descriptions below). For cell
seeding, 250 ml of cell suspension was carefully pipetted on the
MSN and MSN-DOPC films, or uncoated glass cover slips, and cells
were left to adhere for 5–6 h before addition of 2 ml medium. For
flow cytometry, cells were washed with PBS and detached from the
cover slips using 0.05% trypsin in EDTA. Detached cells were dis-
persed in cell culture medium and collected by centrifugation at
300 rcf for 3 min. The cell pellet was washed once with PBS and
dispersed in 200 ml PBS. Samples were stored on ice until analysis.
To conserve cells for morphological analysis, cell monolayers were
fixed at desired confluency using 4% PFA in PBS. Samples were
stored in PBS at 4 C until staining.
2.3.1. Assessment of cytotoxicity of MSN and MSN-DOPC films
Cytotoxicity of MSN and MSN-DOPC films was evaluated by
measuring extracellular lactate dehydrogenase (LDH) activity.
hMSCs expanded in basic medium were detached at a confluence
of 70–80% and seeded on MSN and MSN-DOPC films at a density
of 5000 cells/cm2. After 1, 5 and 7 days of culture, aliquots of the
medium were taken and the same volume of fresh medium was
added to the wells. Cells grown on uncoated, O2 plasma surface-
activated cover slips were used as negative control. To determine
maximal extracellular LDH, cells grown on uncoated, O2 plasma
surface-activated cover slips were permeabilized by adding 3% Tri-
ton X-100 to the medium and incubating for 20 min at 37 C before
taking aliquots of the medium. Amount of extracellular LDH was
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Fisher Scientific, US).
2.3.2. Cellular adhesion on MSN films
Cellular adhesion on MSN films was made visible by immuno-
histochemical staining of the focal adhesion protein vinculin.
hMSCs were seeded on MSN and MSN-DOPC films (over the whole
well surface) at a density of 1000 cells/cm2 and 10,000 cells/cm2
for culturing for 2 and 5 days, respectively. At 2 and 5 d, cells were
fixed with 4% PFA. Prior to staining, cells were washed once with
PBS and permeabilized with Triton X-100 (0.01% (vol/vol) in PBS)
for 10 min at room temperature followed by washing three times
with PBS. Samples were then incubated for 60 min in blocking buf-
fer (10% BSA and 0.05% (vol/vol) Tween-20 in PBS) at room temper-
ature. Mouse monoclonal IgG1 anti-vinculin antibody (SPM227,
1:500; Abcam) was used as the primary antibody and incubated
with the cells overnight at 4 C in the dark. Then, samples were
washed with washing buffer (blocking buffer diluted 1:5 in PBS)
and incubated overnight at 4 C with the secondary antibody,
biotin-conjugated, rabbit anti-mouse IgG1 (1:1000; Sigma
Aldrich). After washing, samples were incubated for 1 h with strep-
tavidin Alexa FluorTM 647 conjugate (1:200; Fisher Scientific), fol-
lowed by washing thrice with washing buffer. All antibody
dilutions were prepared with washing buffer (blocking buffer
diluted 1:5 in PBS).
To visualize actin bundles, cells were stained with Alexa Flu-
orTM 488 phalloidin (1:200 in PBS; Thermo Fisher Scientific) for
20 min at room temperature, followed by washing three times
with PBS. To visualize cell nuclei, samples were incubated for
6 min with 40,6-Diamidin-2-phenylindol (DAPI, 1:70 in PBS; Sigma
Aldrich) at room temperature, washed thrice with PBS and
mounted with Mowiol (Sigma Aldrich). Cells were imaged in with
a Nikon Eclipse Ti-E microscope (Nikon Instruments Europe BV, the
Netherlands) using an oil objective. Images were further processed
and merged using ImageJ.
2.3.3. MSN uptake, calcein loading and release
Stability of the films in solution was assessed by release exper-
iments. To assess cellular uptake of MSNs and their loaded cargo
from the films, hMSCs were seeded on spin-coated cover slips with
ATTO 633 core-labelled MSNs loaded with calcein. Uncoated, O2
plasma surface-activated cover slips were used as a negative con-
trol. hMSCs cultured on tissue-culture plastic with addition of
calcein-loaded MSN to the medium (35 mg/ml) were used as a pos-
itive control. Seeding densities were varied as follows for the dif-
ferent time points in order to obtain similar numbers of cells at
the time of harvest and measurement—2 h and 6 h: 10,000 cells/
cm2; 1 d: 7500 cells/cm2; 2 d: 5000 cells/cm2; 7 d: 3000 cells/
cm2. Cellular uptake was measured using flow cytometry (Accuri
B6 flow cytometer, BD Biosciences, US). Negative controls were
used to gate living cells (P1). Samples were analysed aiming at
10,000 events within P1.
To determine the release kinetics of calcein dyes from MSNs
and MSN-DOPCs in suspension and from films, MSNs were loaded
by suspending them in a 25 mM aqueous calcein solution at a con-
centration of 0.5 mg/ml and stirring for 3 h in the dark. Thereafter,
MSNs and MSN-DOPCs were collected and washed once with bi-
distilled water before spin-coating. Supernatant and washing solu-
tions were collected to determine the amount of loaded cargo
using a Cary 300 fluorometer (Agilent Technologies, US).
Calcein AM blue release from MSNs and MSN-DOPC in suspen-
sion was monitored using a fluorometer. Calcein-loaded MSNs and
MSN-DOPCs (1 mg) were suspended in 200 ml PBS in a membrane-
containing insert, placed in a cuvette and dialysed against 3.2 ml
PBS. Fluorescent signal intensity was measured at 435 nm over
34 h at room temperature to assess release kinetics. Release ofcalcein from MSN and MSN-DOPC films was measured by incubat-
ing spin-coated MSN and MSN-DOPC films in 2 ml PBS under
dynamic conditions. At 1 and 2 d for MSN films and 2 h, 6 h, and
1 d for MSN-DOPC films, aliquots of the supernatant were sampled
and analysed for fluorescent signal intensity at 514 nm.
2.4. Dex loading
To investigate the applicability of MSN films for drug delivery in
a biological setting, the particles were loaded with the
osteogenesis-stimulating drug dexamethasone (Dex) prior to
spin-coating. Loading of Dex was performed by suspending 1 mg
MSNs in a 200 ml 10 mM Dex solution in ethanol. After stirring
overnight, MSNs were collected by centrifugation and suspended
in bi-distilled water for spin-coating. Uncoated, O2 plasma-
activated cover slips and unloaded MSN films served as controls.
Samples were washed shortly with PBS to avoid premature drug
release before transfer into sterile plates for cell experiments.
hMSCs were seeded on top of the MSN films at a density of
4000 cells/cm2. Cells on Dex-loaded MSN films were either cul-
tured in basic medium and all media was refreshed, in basic med-
ium but only half of the medium was refreshed each time (basic
50%) or in medium enriched with 10 nM Dex (osteogenic medium)
and all media was refreshed. Cells on unloaded MSN films were
cultured in basic medium to investigate the effect of the MSNs
themselves on osteogenic differentiation and all media was
refreshed. Control cover slips were either cultured in basic medium
(negative control) or osteogenic medium (positive control) and all
media was refreshed. Medium was refreshed every 3–4 days.
2.5. ALP assay
Osteogenic differentiation was evaluated by measuring alkaline
phosphatase (ALP) levels at day 7, 14 and 21 of culture. CyQuant
Cell Proliferation Assay Kit (Thermo Fisher Scientific) was used to
measure DNA content for normalization of ALP levels. To measure
ALP levels and DNA content, cells were lysed with cell-lysis buffer
(provided with the kit, 1:20 in PBS) containing 0.1% (vol/vol) RNAse
A (Thermo Fisher Scientific) and three cycles of freezing-thawing at
80 C. First, medium was discarded, and cell layers were washed
once with PBS. After freezing-thawing for 30 min, RNAse lysis buf-
fer was added to each well, and samples were frozen-thawed for
two cycles of 30 min each. Once thawed, more RNAse lysis buffer
was added, and samples were sonicated for 5 min. To assure com-
plete lysis of the cells, samples were then incubated for 60 min at
room temperature.
ALP activity was quantified using CDP-star solution (ready-to-
use, Sigma Aldrich). Cell lysate was incubated 1:5 with the reagent
for 30 min in the dark at room temperature in a white-bottom, 96-
well plate. Luminescent signal was read on a spectrophotometer.
ALP values were normalized with total DNA content per sample
and expressed as an x-fold increase compared to the negative
control.
For the quantification of total DNA content, cell lysate was
mixed with GR-dye solution (provided in the CyQuant kit, 1:200
in lysis buffer) according to the supplier’s instructions. After
15 min, fluorescent signal was measured with a spectrophotome-
ter at 520 nm. Absolute amount of DNA was calculated using the
standard curve prepared following the supplier’s instructions.
2.5.1. Mineralization assay
Osteogenic differentiation of hMSCs on MSN films was further
assessed by Alizarin Red S (sodium alizarin sulphonate) staining
to visualize mineralization. For this purpose, cells were seeded
on Dex-loaded MSN films, unloaded MSN films or O2 plasma-
activated cover slips as described above. Cells on Dex-loaded
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10 mM b-glyerolphosphate (BGP) referred to as BGP medium, in
BGP medium but only half of the medium was refreshed each time
(BGP 50%) or in mineralization medium (basic medium with addi-
tion of 10 nM Dex and 10 mM BGP). Cells on unloaded MSN films
were cultured in phosphate medium to investigate the effect of
Dex loading. Control cover slips were either cultured in basic med-
ium (negative control) or mineralization medium (positive control)
where all medium was refreshed every 3–4 days. After 28 d of cul-
ture, cells were fixed with 4% PFA, and calcium deposits were made
visible by Alizarin Red S staining.
In short, Alizarin Red S was dissolved in bi-distilled water at a
concentration of 22 mg/ml. Once the solid was completely dis-
solved, pH was adjusted to 4.2 with 25% ammonium hydroxide,
and the solution was filtered through a 0.45-mm membrane. Prior
to staining, cells were rinsed once with PBS followed by washing
twice with bi-distilled water. Alizarin Red solution was filtered
once more using a 0.45-mm membrane before addition to the sam-
ples. The completely immersed samples were incubated for 2 min
at room temperature followed by washing thrice with bi-distilled
water. Staining was assessed by visual inspection.2.6. Data analysis
Flow cytometry data was analysed using FlowJo software, Ver-
sion 10 (FlowJo LLC, US). Microscopy images were processed using
NIS software for background correction and ImageJ for merging
channels. Statistical analysis was performed using IBM SPSS
software, Version 25, (IBM corporate, US). Significant differences
between groups were examined using non-parametric Kruskal-
Wallis test with Mann-Whitney post-hoc test and Bonferroni cor-
rection after assessment of data distribution and homogeneity of
variances with Shapiro-Wilk test and Lavene’s test, respectively.
For comparison of two groups only, Mann-Whitney U test was
used. Statistical significance was denoted as *p < 0.05, **p < 0.01,
and ***p < 0.001. All data is reported as mean ± standard error of
the mean (SEM).
Cells stained with phalloidin and DAPI were used for quantita-
tive analysis of the cell morphology, in terms of cell area (mea-
sured by the number of pixels occupied) and form factor
(numbers closer to 1 describes rounder cells). Segmentation and
single-cell morphological measurements were performed by com-
bining ImageJ for image processing, Cell Profiler for segmentation
and cell tracking [27] and Matlab 2016b (Mathworks) for data
analysis (grouping, matching and plotting the quantitative data
generated from each image dataset). A schematic of this data anal-
ysis process is shown in Scheme S1.3. Results
3.1. MSN-based films are homogeneous and stable
Spherical mesoporous silica nanoparticles (MSNs) with thiol-
functionalized cores and amine-functionalized surfaces were syn-
thesized based on a previously reported co-condensation method
[25]. The thiol groups allowed covalent coupling of fluorescent
dyes without interfering with surface chemistry. SEM imaging con-
firmed the synthesis of spherical and evenly shaped MSNs with a
diameter of 80 nm (Fig. 1A) and TEM analysis showed their meso-
porous structure (Fig. 1B). Presence of the surface (amine) and core
(thiol) functionalities was confirmed by fluorescent labelling with
ATTO633 maleimide and FITC-NHS coupled to the thiol and amine
groups of MSNs, respectively (Fig. 1C). Amine groups on the surface
of the MSNs resulted in a positive surface charge as confirmed by
zeta potential measurements (40.7 ± 0.5 mV). The MSNs had apolydispersity index (PdI) of 0.13 ± 0.01, showing that the particles
were monodisperse.
To create nanoparticle-based films, spin-coating of MSN sus-
pensions in ethanol was performed on surface-activated glass
cover slips. SEM imaging revealed the deposition of continuous
layers of nanoparticles with a homogeneous surface structure
(Fig. 1D). The film thickness distribution was even over the glass
slide and measured 95 ± 3 nm, determined by 3D laser scanning
microscopy (Fig. S1A). The films were stable in aqueous conditions;
no significant MSN diffusion from the films could be detected after
7 d and 14 d of incubation in PBS (Table S1) and films remained
intact (Fig. S1B).
Next, MSN film stability under cell culture conditions was
investigated by determining MSN uptake in hMSCs, measured by
fluorescently labeled thiols present in the MSN core (Fig. 1E). After
1 d, 5.4 ± 0.5% of hMSCs had taken up MSNs from the films com-
pared to 22.9 ± 2.9% of hMSCs when MSNs were added as a suspen-
sion (Fig. 1E). No change was observed after 2 d, with 6.5 ± 0.3%
MSN-positive cells when cultured on films compared to
23.4 ± 2.0% when added in suspension. This remained stable after
7 d (3.94 ± 0.89%) and did not increase significantly after 14 d
(8.5 ± 1.71%, Table S2), indicating that MSN films were stable under
cell culture conditions.
3.2. MSN-based films are biocompatible and support cell adhesion
Having established that the functionalized MSN films were
homogeneous and stable under cell culture conditions, we investi-
gated the biocompatibility and the ability of hMSCs to attach and
proliferate on MSN films. hMSCs were chosen as they are inten-
sively investigated in tissue regenerative strategies due to their
multipotency (inherent ability to differentiate into multiple lin-
eages) and ease of isolation. To test biocompatibility of the MSN
films in the short term, cell viability was determined for hMSCs
cultured on MSN films after 1, 5 and 7 days using the LDH assay.
No difference in extracellular LDH levels was observed between
cells cultured on the films compared to controls, suggesting no
negative effect of the MSN films on cell viability (Fig. 2A). To vali-
date that culturing hMSCs on MSN films did not affect cell numbers
at later time-points, DNA was quantified after 7, 14 and 21 days.
The DNA content was comparable on MSN films and control glass
slides at 7d of culture, demonstrating similar proliferation rates of
hMSCs cultured on films or glass (Fig. 2B). For both conditions, a
significant increase in cell numbers was observed after 14 d of cul-
ture due to proliferating cells. A small but significant difference in
DNA content was found between the samples at 14 d. However, no
significant difference was observed between the samples on day 7
or 21, indicating that it had a neglible effect on overall cell number.
Furthermore, cell numbers did not significantly increase after 14 d
for either hMSCs cultured on the films or on control slides, indicat-
ing that the hMSCs reached confluency after this time in both con-
ditions slowing down proliferation rates.
Given the impact of hMSC cell attachment in guiding cellular
differentiation through the formation of focal adhesions
[2,28,29], cell adhesion of hMSCs on MSN films was investigated
using SEM and vinculin antibody staining. Cell attachment to the
extracellular matrix or other substrates mainly occurs through
the formation of stress fibres and clustering of different focal adhe-
sion proteins (including vinculin), followed by the maturation of
these contact points [2]. hMSCs cultured on MSN films for 2 days
showed cell-typical morphology with extended filopodia where
the films remained intact (Fig. 2C). The formation of focal adhe-
sions was also observed using fluorescence microscopy and vin-
culin staining (Fig. 2D, E). No differences could be observed in
the number or extent of bundling of actin to form stress fibres in
hMSCs grown on MSN films or control glass after 2 (Fig. 2D) or
Fig. 1. Characterization of MSNs and spin-coated MSN films. (A) Scanning electron microscopy (SEM) images of spherical MSNs. Scale bar represents 1 lm. (B) Transmission
electron microscopy (TEM) image of MSN pore structure. Scale bar represents 100 nm (C) Fluorescence microscopy images of MSNs with thiol core (red) and amine surface
(green) functionalization. Merge indicates co-localization of amine and thiol groups. Scale bar represents 20 lm. (D) SEM image showing the surface structure of spin-coated
MSN films. Scale bar represents 1 lm. (E) MSN uptake by hMSCs from MSN films and colloidal suspension. Data shown as mean ± SEM from 3 samples. (For interpretation of
the references to colour in this figure legend, the reader is referred to the web version of this article.)
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biocompatible and support hMSC proliferation and cell adhesion
similar to hMSCs grown on control surfaces.
3.3. MSN films can deliver biomolecules to instruct stem cells
MSNs have a high loading capacity and can efficiently encapsu-
late a variety of cargo, ranging from hydrophilic to hydrophobic
drugs [20,21,30]. We thus tested the ability of the MSN films to
store and deliver biomolecules, first using calcein—a cell-
penetrable, fluorescent dye—as model cargo. To this end, calcein
loaded MSNs were spin-coated on glass slides and calcein uptake
by hMSCs was measured using flow cytometry. To compare calcein
uptake between film and suspension conditions, calcein loaded
MSNs were added to hMSCs cultures as a colloidal suspension (in
equal amounts). Cellular uptake of calcein was 1.3-fold greater
after 1 d (Figs. 3A and S2, left) and 2.6-fold greater after 2 d
(Figs. 3A and S2, right) in hMSCs cultured on the MSN films com-
pared to those exposed to the colloidal calcein loaded MSN suspen-
sion. The uptake of calcein by hMSCs when adding MSNs in
suspension was stable over 2 d, consistent with previous findingsthat MSNs in suspensions are internalized in hMSCs within the first
few hours of culture [31].
Next, we tested the release of a relevant biomolecule from the
MSN films—Dex, a synthetic glucocorticoid known to induce the
expression of osteogenic marker genes in bone marrow cells
[32,33]. Dex was selected as a model osteogenic factor, because
its effects on alkaline phosphatase (ALP) production, an important
osteogenic marker, are well studied [34]. hMSCs were cultured on
glass slides under normal cell culture conditions (negative control,
i.e. basic medium) and with 10 nM Dex supplementation (positive
control, i.e. osteogenic medium), and all media was exchanged
every 3–4 days. For hMSCs cultured on MSN films the following
conditions were included; MSN (hMSCs cultured on MSN-film,
100% basic media exchange every 3–4 days), MSN-Dex (hMSCs cul-
tured on Dex-incorporated MSN-film, 100% basic media exchange
every 3–4 days), MSN-Dex 50% (hMSCs cultured on Dex-
incorporated MSN-film, 50% basic media exchange every 3–
4 days), MSN-Dex osteo (hMSCs cultured on Dex-incorporated
MSN-film, 100% osteogenic media exchange every 3–4 days). ALP
levels were measured to determine the efficacy of Dex released
from the films on osteogenic differentiation of hMSCs films.
Fig. 2. Viability, proliferation and adhesion of hMSCs on MSN films. (A) Viability of hMSCs based on extracellular lactate dehydrogenase levels for cells cultured on glass
(control) or MSN films for 1, 5 and 7 days. (B) Proliferation of hMSCs cultured on glass (control) or MSN films for 7, 14 and 21 days. For A and B, data shown as mean ± SEM
from biological triplicates, *p < 0.05. (C) SEM images of hMSCs cultured on MSN films for 2 days. Scale bar represents 2 lm, inserts show formation of extended filopodia on
MSN films. Fluorescence microscopy images of focal adhesions of hMSCs cultured on MSN film (left) or glass (right) for (D) 2 and (E) 5 days. Scale bars represent 50 lm, green
is actin (phalloidin), red are focal adhesions (vinculin) and blue are nuclei (DAPI) staining. (For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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fold higher (p < 0.01) after 14 d for hMSCs cultured on Dex-
loaded MSN films (and 50% refreshed medium) compared to those
cultured on negative controls (Fig. 3B). These ALP levels were also
higher compared to the positive control, Dex added to the medium
(osteogenic medium), which showed 3.9-fold (p < 0.01) and 5.8-
fold (p < 0.01) after 7 and 14 d of culture, respectively. No signifi-
cant ALP increase was found on Dex-loaded MSN films where all
media was exchanged every 3–4 days (removing all released
Dex), compared to the negative control.
In addition to ALP levels, we assessed matrix mineralization, a
crucial step for the formation of hard tissues and considered the
last stage of osteoblast differentiation [35]. Matrix mineralization
was determined by staining calcium deposition in hMSCs after
28 d of culture. Mineralization could be observed in the positive
controls which consisted of hMSCs cultured on glass substrates
in the presence of BGP- and Dex- supplemented media which
was fully replenished every 3–4 days (i.e. mineralization medium).
MSN films that incorporated Dex where the media was fully
exchanged every 3–4 days resulted in comparable mineralization
as observed in the positive controls. However, similar to our previ-
ous observation concerning the ALP levels, the strongest mineral-
ization was found on Dex-loaded MSN films when half of the
medium was refreshed every 3–4 days, which was also substan-
tially higher than positive controls (Figs. 3C and S3).
In summary, MSN films loaded with Dex resulted in higher ALP
levels in hMSCs and increased mineralization compared to positive
controls where Dex was added to the medium.3.4. MSN-DOPC films affect cell morphology
To determine whether we could modulate cargo release from
the MSN films, surface modification of MSNs with SLB was
investigated. Next to good biocompatibility and low toxicity, SLB
have been shown to improve cargo retention and facilitate
stimuli-responsive release [26,36]. In addition to functioning as
gate-keepers, SLBs are also a promising platform to create dynamic
biological interfaces to control cell behaviour. In particular, where
the head group of the lipid determines the interaction with cells,
the alkyl chain composition defines the phase behaviour of the
SLB (i.e. mobility of the lipids within the SLB) [24]. The formation
of SLB around MSN is based on a solvent-exchange method: the
water content of an ethanolic lipid monomer solution is gradually
increased, resulting in the self-assembly of a lipid bilayer on the
solid MSN surface [23,26]. Here we used 1,2-dioleoyl-sn-glycero-
3-phosphocholine (DOPC) lipid to create MSN-DOPC, which con-
sists of a zwitter ionic head group providing a protein-resistant
surface, and a low melting temperature resulting in a mobile lipid
layer. Successful SLB formation was confirmed by a decrease in
zeta surface potential for DOPC-coated MSNs (8.7 ± 0.2 mV) com-
pared to uncoated MSN (40.7 ± 0.5 mV), with a PdI of 0.30 ± 0.01.
The development of films using MSN-DOPC was only possible
when spin-coating MSN-DOPC mixed with plain MSNs (ratio
1:1). Spin-coating MSN-DOPC particles alone would form aggre-
gates on the glass and it was not possible to form homogeneous
films. The continuous, MSN: MSN-DOPC (1:1) films showed a
homogenous surface structure (Fig. 4A), with a thickness of
Fig. 3. Drug delivery capacity of MSN films to induce osteogenic differentiation in hMSCs. (A) Histograms of calcein uptake, determined by fluorescence intensity, from hMSCs
cultured on MSN films, or with MSN suspensions. As a negative control, hMSCs were cultured on glass without MSNs. (B) Alkaline phosphatase production of hMSCs cultured
on dexamethasone-free (MSN) or dexamethasone-loaded MSN films (DEX-MSN) in basic medium. DEX-MSN 50% refers to refreshing half of the medium. Controls were
cultured on glass in basic (negative control) or dexamethasone-supplemented osteogenic medium (positive control), with full media replenishment every 3–4 days. Values
are x-fold increases compared to the negative control. Data is shown as mean ± SEM of biological triplicates. * Significant difference compared to neg control, # compared to
MSN basic. *p < 0.05; **p > 0.01. (C) Visualization of calcium deposits (red) by hMSCs after 28 days of culture. In experimental conditions, cells were cultured on
dexamethasone-loaded MSN films with addition b-glycerolphosphate (BGP) to the medium where either all (BGP) or only half of the medium (BGP 50%) was changed every
3–4 days. hMSCs were cultured on glass cover slips in basic medium (negative control) or mineralization medium containing dexamethasone and b- glycerolphosphate
(positive control), with full media replenishment every 3–4 days. Representative images of calcium deposits per condition are shown, scale bar represents 2 mm. (For
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 4. MSNs films with supported lipid bilayer (SLB) surface functionalization. (A) SEM image showing the surface structure of SLB-modified (DOPC) MSN films. Scale bar
represents 1 lm. (B) MSN uptake by hMSCs from MSN-DOPC films and in a colloidal suspension. (C) Viability, based on extracellular lactate dehydrogenase levels, of hMSCs
cultured on glass (control) or MSN-DOPC films for 1, 5 and 7 days. (D) Proliferation of hMSCs cultured on glass (control) or MSN-DOPC films for 7, 14 and 21 days. For panels
B–D, data shown as mean ± SEM biological triplicates.
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Fig. 5. hMSCs grown on MSN-DOPC are significantly smaller and rounder compared to hMSCs grown on unmodified MSN films and on glass surfaces. Box plots showing the
(A) area, (B) perimeter and (C) form factor of hMSCs grown onMSN-DOPC, MSN and control surfaces after 3 days. Data are mean ± SEM from x. *p < 0.01; **p < 0.01; ***p < 0.001
Upper border and lower border of the boxes are third quartile and first quartile accordingly. + are mean of each data group; ns is non-significant.
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DOPC before spin-coating, small pockets of MSN-DOPC nanoparti-
cles could be detected, which were homogeneously dispersed
(Fig. S4C). MSN-DOPC films were stable in PBS (Table S1,
Fig. S4D) and hMSCs cultured on MSN-DOPC films showed very
low uptake of MSNs also after 7 and 14 days of culture, demon-
strating that the lipid surface modification did not affect film sta-
bility (Fig. 4B, Table S2). No difference in cell viability, measured
by extracellular LDH levels, was observed between cells cultured
on MSN-DOPC films and glass slide controls, indicating that the
films were biocompatible (Fig. 4C). In addition, hMSCs cultured
on MSN-DOPC films were viable and proliferated to a similar
extent compared to hMSCs cultured on glass (Fig. 4D).
Next, we evaluated the effect of MSN-DOPC on hMSC cell shape
factors. Cell area, cell perimeter and circularity (form factor
approaches 1 for highly circular cells) were quantified and com-
pared to cells grown on MSN films and control glass (Fig. 5). hMSCs
grown on MSN-DOPC films showed a significant reduction in cell
perimeter (21%) and cell area (15%) compared to hMSCs grown
on control glass. A significantly higher form factor was found for
hMSCs cultured on MSN-DOPC (0.24 vs. 0.18 for control surfaces,
Fig. 5), indicating more circular cells. Cell perimeter and area were
also reduced for hMSCs grown on MSN films, but the effect was
much smaller: 5% cell perimeter, 11% cell area. The form factor
of hMSCs grown on MSN films was similar to hMSCs cultured on
control surfaces (0.18, Fig. 5C), demonstrating that the hMSCs
maintained the same shape at a slightly smaller size. Thus, the
addition of the SLB on MSN films resulted in smaller and rounder
hMSCs.
3.5. MSN-DOPC films release their cargo slower compared to MSN
films
To determine whether MSN-DOPC films, like MSN films, could
release biomolecules, we incorporated calcein again as a model
cargo in the MSN-DOPCs before spin-coating. As shown in
Fig. 6A, <10% of calcein was released over 34 h, with a dampened
initial burst, from MSN-DOPC film compared to calcein release
from MSN films. Additionally, hMSCs cultured on MSN-DOPC films
took up less calcein compared to those cultured on MSN films, as
seen in the median fluorescence intensity representing intracellu-
lar calcein concentration (Figs. 6B and S5). We found a 3.0-fold
higher intensity from unmodified MSN films compared to DOPC-
modified films at 2 h, which continued for later time points, with
a 3.6-fold and 2.0-fold higher intensity after 6 h and 1 d, respec-
tively. The same trend was seen when assessing the percentages
of calcein-positive hMSCs. After 2 h of culture, only 12.8 ± 3.9% of
hMSCs cultured on SLB-modified MSN films had taken up calcein
compared to 48.8 ± 6.7% of hMSCs on MSN films. The percentageof calcein-positive cells increased to 25.1 ± 5.1% and 65.8 ± 15.8%
on MSN-DOPC and MSN films, respectively, after 6 h. After 1 d,
77.9 ± 8.5% of hMSCs on DOPC-modified MSC films had taken up
calcein compared to 97.0 ± 2.6% on unmodified MSN films. Next,
Dex was incorporated in MSN-DOPC and spin-coated with non-
loaded MSNs in a 1:1 ratio. The ALP production of hMSCs cultured
on Dex-loaded MSN-DOPC films when all basic media was replen-
ished every 3–4 days was compared to Dex-loaded on MSN films
where again only 50% of the basic media was replenished every
3–4 days. Whereas after 7 d no significant difference could be
detected (Fig. 6C), after 14 d a significant increase in ALP levels
for hMSCs cultured on MSN-DOPC films (2.1-fold, p < 0.01) com-
pared to negative controls (full media replenishment) was
observed. However, these levels were lower compared to the pos-
itive control (4.6-fold, p < 0.01, full media replenishment) and to
hMSCs cultured on Dex-incorporated MSN films where 50% of
the media was replenished (6.4-fold, p < 0.01 Fig. S6C).
In summary, by using the SLB surface modification, calcein and
Dex diffused more slowly from the MSN films, which resulted in
significant ALP production.4. Discussion
Here we report a nanostructured surface coating that offers
high control over surface chemistry and which can simultaneously
be used to deliver bioactive factors. It is well documented that sur-
face structure (topography) can be used to control important cellu-
lar and molecular events, for example, to promote adhesion and
integration of the surrounding tissue [1–3,37,38]. Moreover, the
use of soluble factors has been a popular approach to improve
the bioactivity of synthetic biomaterials [9–11]. Our approach
leverages the drug delivery capabilities of MSNs; their porous
structure can be used to incorporate different types of cargo, while
their surface can be easily modified to tune their release kinetics
[12,13]. These features are combined with their promising surface
characteristics, which support cell adhesion and proliferation but
can also be used to chemically modify the surface to provide sur-
face cues (e.g. to modulate cell shape). Although here we used
Dex as a soluble factor and lipid bilayers as surface modifications,
many other types of cargo and surface modifications can be used.
To create the films, core- and surface-functionalized (80 nm
sized) MSNs were synthesized and spin-coated on (plasma-
treated) glass slides to create stable homogeneous films. The films
were also stable under cell culture conditions, i.e. hMSCs cultured
on the films did not significantly internalize MSNs. Moreover,
DOPC lipid surface modifications did not affect film stability. These
findings are in contrast with a study by Bocking et al. [39], who
reported prominent cell uptake of MSNs from films after 24 h. This
Fig. 6. Modulation of calcein release kinetics by supported lipid bilayer (SLB) in MSN films and effect of Dex release from MSN-DOPC films on ALP production. (A) Cumulative
percentages of released calcein based on feeding solution for unmodified (MSN) and SLB-modified (DOPC) MSN films. (B) FACS histograms measuring calcein uptake by
hMSCs cultured on MSN film, MSN-DOPC film, and glass (negative control) after 2 h (left), 6 h (middle), and 1 d (right). (C). Alkaline phosphatase production of hMSCs
cultured on dexamethasone-loaded MSN-DOPC films when refreshing all of the medium, or MSN films when refreshing half of the medium (DEX-MSN 50%) every 3–4 days.
For controls, hMSCs were cultured on glass in basic (negative control) or dexamethasone-supplemented osteogenic medium (positive control) and all media refreshed every
3–4 days. Values are x-fold increases compared to the negative control. Data is shown as mean ± SEM of biological triplicates. **Significant difference compared to neg control
(p < 0.01).
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tion of MSN films between the two studies. First, our MSNs are
surface-functionalized with positively charged amines, whereas
the Bocking study utilized non-surface-modified MSNs. The posi-
tively charged amines would give the MSNs a strong affinity to
the negatively charged, O2 plasma–treated spinning substrate, thus
yielding more stable MSN films. Second, a different cell type
(C2C12 myoblasts) was used, which may have more permissive
uptake routes compared to the hMSCs used here. The benefit of a
stable film as developed here is the locally retained drug delivery
(near the film), and sustained drug release (slow diffusion from
MSN pores) without effecting coating integrity. However, their sur-
face chemistry can easily be adjusted to create less stable films (e.g.
by lowering MSN surface zeta potential) to also allow nanoparticle
delivery in cells, as previously demonstrated by Bocking et al. [39].
hMSCs cultured on MSN films showed cell-typical morphology
with extended filopodia, and formed focal adhesion points to a
similar extend as hMSCs grown on glass surfaces. Also, no signifi-
cant influence on cell shape (form factor) could be observed for
cells grown on MSN films and flat controls. This is in line with lit-
erature; contact guidance (the instruction of cells to align or spread
in a certain shape by surface topography) has mainly been reported
for micro-sized grooves or pillars [1–3]. Thus, MSN films can serve
as a biocompatible cell-adherent nanomaterial without affecting
cell shape, cell adhesion or proliferation rates. The cell-adhesive
properties of MSNs have already been documented in othersystems: MSN addition to hydrogel networks has led to improved
stem cell adhesion, migration and spreading [17–19].
MSN surface functionalization with lipids (DOPC), did signifi-
cantly affect hMSC cell shape and size, hMSCs cultured on MSN:
MSN-DOPC (1:1) films were significantly smaller and rounder
compared to hMSCs cultured on glass slides or pure MSN-films.
The antifouling properties of PC lipids like DOPC are well known
and are attributed to the zwitterionic lipid head group [24]. Pre-
viously, it has been shown that SLBs made from DOPC on a flat
surface (so not on nanoparticle surfaces) prevented stem cell
adhesion [38]. Here, the 1:1 mix of cell-adherent surface (MSN)
and cell-resistant surface (MSN-DOPC) did not interfere with
hMSC cell number or proliferation rate but did allow for the mod-
ulation of stem cell shape and size. This is likely due to less avail-
able cell adhesion sites on the MSN: MSN-DOPC surface
compared to the MSN-films. SLB nanoparticle surface modifica-
tion thus seem to be an interesting approach to control hMSC
adhesion and spreading on nanoparticle-based films. Moreover,
cell shape has been shown to be an important regulator of stem
cell differentiation, where hMSCs cell spreading has been linked
with osteogenesis [37,38]. Future studies should investigate
whether MSN-supported lipid films as the ones proposed here
can have a similar effect in directing stem cell fate by modulating
cell shape.
The porous structure of the MSNs allowed efficient encapsula-
tion of calcein dye and Dex, a synthetic glucocorticoid known to
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from the films was more efficient compared to administration of
the same amount of MSNs as a suspension. Since we observed
co-localization of calcein and MSN particles, it is likely that calcein
uptake is directly related to MSN uptake when MSNs are added as a
suspension. In contrast, calcein can diffuse from the MSN films,
leading to locally higher calcein concentrations. Thus, hMSCs in
direct contact with the MSNs in the MSN films are exposed to
higher cargo concentrations. The higher local cargo concentrations
near the film and thus near the adhered cells, could also explain
the several fold increase in ALP signal and a significantly higher
mineralization when Dex was incorporated in the film, compared
to positive control conditions (i.e. Dex directly added to the med-
ium). ALP production and mineralization has been shown to be
Dex concentration-dependent [40], indicating that the higher local
Dex concentrations when using Dex-loaded MSN-films may lead to
improved bone forming potential of hMSCs. Efficient drug delivery
from stable MSN-based coatings has previously been reported for
the delivery of small molecule RAPA, which led to a higher re-
endothialization in vivo compared to RAPA incorporating polymer
controls [41].
However, increased ALP levels and mineralization was only
observed when 50% of the medium was exchanged compared to
control conditions where all medium was exchanged. Replenishing
media every 3–4 days is needed because of the long culture condi-
tions (up to 21 days for ALP and up to 28 days for mineralization
assays). Whereas in the positive controls Dex is presented to the
cells as a homogeneous solution, in the case of the MSN-films,
Dex is locally released from the films. Thus, when fully exchanging
media, released Dex from the MSN-film was completely removed
every 3–4 days, indicating that Dex release was not sustained over
the full 21 days period. Since the in vitro differentiation of hMSCs
towards an adult lineage relies on continuous presence of bioactive
molecules, we pursued the possibility of using lipid bilayer surface
functionalization to slow down cargo release. The lipid surface
modification has been used by us and others to create biocompat-
ible MSNs that allow sustained cargo release by blocking the MSN
pores [23,26,31]. Indeed, we could show that using a lipid bilayer,
calcein delivery was significantly slowed down; both from the
films and when hMSCs were cultured on MSN-DOPC films. Espe-
cially the initial burst release could be dampened when using
DOPC, and release of calcein over several days was significantly
slowed down. The slower release of Dex from MSN-DOPC also
led to a significant increase in ALP levels after 14 days when all
media was removed every 3–4 days, albeit lower compared to pos-
itive controls and Dex-incorporated MSN films where only 50% of
the media was replenished. Future studies should be directed into
investigating the potential of such coatings in vivo where the local
Dex concentrations are likely to remain higher. Thus, surface mod-
ifications like SLB can help to provide a more sustained cargo
release which may better mimic the spatiotemporal appearance
of biological cues during regeneration and improve the bioactivity
of synthetic materials.5. Conclusions
In summary, MSNs can be used to create an adherent biocom-
patible and stable nanostructured surface that can be chemically
modified to instruct cell behaviour both by providing surface cues
and soluble cues. As far as we are aware, our study is the first one
to prepare stable MSN-based films for sustained release of cargo,
where the release could be modulated by using lipid surface
modifications.
Specifically, we demonstrated efficient local Dex delivery from
mesoporous silica nanoparticle-based films to direct hMSCdifferentiation towards the bone lineage without affecting coating
integrity. The stable MSN films supported hMSC cell adhesion and
proliferation, and Dex delivery from the MSN films resulted in
increased levels of osteogenic markers compared to MSN- or
Dex-supplemented medium. In addition, we demonstrate that
SLB surface modification of the nanoparticles allowed the possibil-
ity to modulate release kinetics from the films, offering better
temporal control over Dex release. SLB surface modifications were
possible without affecting film integrity, cell adhesion or prolifera-
tion rates. However SLB surface modifications did affect cell
morphology (size, shape and form factor), representing an
interesting approach to control hMSC adhesion and spreading on
nanoparticle-based films using surface cues. In addition, nanopar-
ticle surface modifications such as SLB offer interesting ways for
sequestered delivery of multiple cargo’s to generate coatings that
can enhance biomaterial performance by (tightly) guiding tissue
formation. In particular, as both MSN types (SLB-modified and
unmodified) can be mixed into the same MSN film, delivery of
multiple cargos but also sequestrated release of the bioactive
molecules may be possible.
In conclusion, MSNs are multi-functional tools for the design of
material coatings with incorporated, sustained drug delivery to
modulate cell behaviour. We envisage the application of these
materials as implant coatings to improve tissue integration and
thereby reducing healing time. For example, future applications
for the developed MSN film include the coating of metal implants
for joint replacement applications, a major orthopaedic procedure
used to treat joint osteoarthritis. Implant failure is a common clin-
ical problem caused by aseptic loosening and infection. The MSN
films can impart bioactivity and biocompatibility to the metallic
surface to promote bone ingrowth and differentiation of stem cells
into osteoblasts leading to enhanced osteointegration.Acknowledgements
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